How do you diagnose Cushing syndrome and what criteria apply, especially in a patient receiving long-term prednisone for a leprosy reaction?

Diagnosing Cushing Syndrome: Approach and Special Considerations for Patients on Long-term Prednisone

The first critical step in diagnosing Cushing syndrome is to exclude exogenous glucocorticoid use—if a patient is taking prednisone for leprosy reaction, you cannot diagnose endogenous Cushing syndrome until the medication is stopped, as exogenous steroids are the most common cause of Cushingoid features. 1, 2

Initial Assessment: Rule Out Exogenous Steroids

• Stop all exogenous glucocorticoids if medically possible before proceeding with diagnostic testing for endogenous Cushing syndrome 1, 3
• Exogenous sources include oral prednisone, injections, inhalers, and topical preparations 1
• Long-term prednisone therapy (as used in leprosy reactions) causes the same clinical findings as endogenous hypercortisolism: obesity with centripetal fat distribution, skin thinning with easy bruising, muscle wasting, hypertension, latent diabetes, osteoporosis, and electrolyte imbalance 2
• The diurnal rhythm of the HPA axis is lost during long-term pharmacologic dose corticosteroid therapy, making it impossible to distinguish from endogenous Cushing disease 2

Screening Tests for Endogenous Cushing Syndrome (Once Exogenous Steroids Excluded)

Perform 2-3 screening tests from the following first-line options: 1

Late-Night Salivary Cortisol (LNSC)

• Collect at least 2 samples at 11 PM-midnight 1, 4
• Reflects loss of normal circadian rhythm (cortisol should be at nadir after sleep) 5
• Pitfall: False positives from inadequate soaking of collection device; false negatives in cyclic Cushing syndrome 5

24-Hour Urinary Free Cortisol (UFC)

• Obtain at least 2-3 collections to account for 50% intra-patient variability 1, 4
• Reflects integrated tissue exposure to free cortisol over 24 hours 5
• UFC values >3-fold above normal strongly suggest true Cushing syndrome rather than pseudo-Cushing 1
• Pitfall: Less reliable with renal impairment (CrCl <60 mL/min) or polyuria (>5 L/24h); requires complete urine collection with appropriate volume 1, 5

Overnight 1-mg Dexamethasone Suppression Test (DST)

• Give 1 mg dexamethasone at 11 PM, measure cortisol at 8 AM 1, 5
• Morning cortisol <50 nmol/L (approximately 1.8 μg/dL) excludes Cushing syndrome 5
• Values >5 μg/dL identify dysregulated cortisol secretion 1
• Pitfall: False positives with CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort), increased CBG from oral estrogens/pregnancy, malabsorption syndromes 1
• Pitfall: False negatives with CYP3A4 inhibitors (fluoxetine, cimetidine, diltiazem) or decreased CBG/albumin (nephrotic syndrome) 1
• Measure dexamethasone levels concomitantly to reduce false-positive results 1

Excluding Pseudo-Cushing Syndrome

If screening tests are mildly abnormal (UFC <3-fold normal), consider non-neoplastic hypercortisolism from: 1

• Psychiatric disorders
• Alcohol use disorder
• Polycystic ovary syndrome
• Severe obesity
• Uncontrolled diabetes
• Pregnancy
• Anorexia/malnutrition
• Acute illness/surgery
• Excessive exercise

Use Dex-CRH test or desmopressin test to distinguish true ACTH-dependent Cushing syndrome from pseudo-Cushing 1

Determining Etiology After Confirming Hypercortisolism

Measure Plasma ACTH

• Low ACTH → ACTH-independent (adrenal) Cushing syndrome 1, 6

  • Proceed to adrenal CT or MRI 1

• Normal or high ACTH → ACTH-dependent Cushing syndrome 1, 6

  • Proceed to pituitary MRI 1

For ACTH-Dependent Cases:

• Pituitary adenoma ≥10 mm: Presumed Cushing disease, no IPSS needed 1
• Pituitary adenoma 6-9 mm: Expert opinions differ; consider IPSS plus CRH/DDAVP testing 1
• Pituitary adenoma <6 mm or no adenoma: Perform IPSS plus whole-body CT to distinguish Cushing disease from ectopic ACTH 1

Critical Considerations for Patients on Long-term Prednisone

You cannot diagnose endogenous Cushing syndrome while a patient is actively taking prednisone for leprosy reaction. 1, 2 The key considerations are:

• Exogenous glucocorticoids suppress ACTH production and adrenal cortisol secretion, making all diagnostic tests unreliable 2
• Recovery time for normal HPA activity after stopping prednisone is variable depending on dose and duration of treatment 2
• Prednisone causes the identical clinical and biochemical picture as Cushing disease, including loss of diurnal HPA rhythm 2
• If prednisone cannot be stopped due to active leprosy reaction, you can only document iatrogenic Cushing syndrome and manage complications (hypertension, diabetes, osteoporosis, infections) 2, 3
• Gradual withdrawal is mandatory if attempting to stop long-term prednisone therapy; abrupt cessation risks adrenal crisis 2

Monitoring During Prednisone Therapy

• Screen for and treat complications: hyperglycemia, hypertension, osteoporosis, infections, mood disorders 3, 6
• Consider alternate-day therapy to minimize HPA suppression and Cushingoid effects if disease control permits 2
• Administer prednisone in the morning (before 9 AM) to minimize adrenal suppression 2